Overview of dual-acting drug methotrexate in different neurological diseases, autoimmune pathologies and cancers

P Koźmiński, PK Halik, R Chesori… - International journal of …, 2020 - mdpi.com
Methotrexate, a structural analogue of folic acid, is one of the most effective and extensively
used drugs for treating many kinds of cancer or severe and resistant forms of autoimmune …

Crossing the blood–brain barrier: recent advances in drug delivery to the brain

MM Patel, BM Patel - CNS drugs, 2017 - Springer
CNS disorders are on the rise despite advancements in our understanding of their
pathophysiological mechanisms. A major hurdle to the treatment of these disorders is the …

The blood-brain barrier: structure, function and therapeutic approaches to cross it

M Tajes, E Ramos-Fernández… - Molecular membrane …, 2014 - Taylor & Francis
The blood-brain barrier (BBB) is constituted by a specialized vascular endothelium that
interacts directly with astrocytes, neurons and pericytes. It protects the brain from the …

Solid lipid nanoparticles for targeted brain drug delivery

P Blasi, S Giovagnoli, A Schoubben, M Ricci… - Advanced drug delivery …, 2007 - Elsevier
The present review discusses the potential use of solid lipid nanoparticles for brain drug
targeting purposes. The state of the art on surfactant-coated poly (alkylcyanoacrylate) …

Getting into the brain: approaches to enhance brain drug delivery

MM Patel, BR Goyal, SV Bhadada, JS Bhatt, AF Amin - CNS drugs, 2009 - Springer
Being the most delicate organ of the body, the brain is protected against potentially toxic
substances by the blood-brain barrier (BBB), which restricts the entry of most …

Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy

S Takeda, N Sato, R Morishita - Frontiers in aging neuroscience, 2014 - frontiersin.org
The incidence of dementia is increasing at an alarming rate, and has become a major public
health concern. Alzheimer disease (AD) is the most common form of dementia and is …

Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Aβ1-42-induced neuroinflammation and neurodegeneration via the NF-KB/JNK …

MJ Kim, SU Rehman, FU Amin, MO Kim - … : Nanotechnology, Biology and …, 2017 - Elsevier
Abstract Amyloid-beta (Aβ 1-42) plaques and neurofibrillary tangles (NFTs) are the main
hallmarks considered to be associated with neuroinflammation in Alzheimer's disease (AD) …

Lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations

K Hu, J Li, Y Shen, W Lu, X Gao, Q Zhang… - Journal of controlled …, 2009 - Elsevier
The lactoferrin (Lf) conjugated poly (ethyleneglycol)–poly (lactide) nanoparticle (Lf–NP) was
constructed in this paper as a novel biodegradable brain drug delivery system with …

Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art

L Gastaldi, L Battaglia, E Peira, D Chirio… - European Journal of …, 2014 - Elsevier
Central nervous system disorders are already prevalent and steadily increasing among
populations worldwide. However, most of the pharmaceuticals present on world markets are …

Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood–brain barrier

J Chang, Y Jallouli, M Kroubi, X Yuan, W Feng… - International journal of …, 2009 - Elsevier
Many studies showed that transferrin increases brain delivery of nanoparticles (NPs) in vivo,
however the mechanisms implied in their brain uptake are not yet clearly elucidated. In this …